Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
Clinical trial NCT02876900 · COMPLETED
Trial details
- NCT number
- NCT02876900
- Sponsor
- Noven Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-06-01
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.